XBI : SPDR S&P Biotech ETF

XBI is a Sector Equity Market Healthcare with LOW fees.

XBI

SPDR S&P Biotech ETF

FI Score

76 /100

Diversification Rating

10 /10

Expense Ratio Rating

9 /10

Expense Rating

7 /10

Market Score

9 /10

Category Score

0 /10

Market Size

9 /10

76% FI Score
  • xbi
  • ETF
  • Sector Equity
  • Healthcare

SPDR S&P Biotech ETF

Expenses: 0.35% (Better than 1% of similar funds)

This is an OK choice for a Healthcare Sector Equity fund. See why ยป

Fund Summary

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI). The fund is non-diversified.

Largest Holdings

Amount Holding
4.13% Moderna, Inc
2.63% Regeneron Pharmaceuticals, Inc
2.35% Immunomedics, Inc
2.24% Exelixis, Inc
2.23% Seattle Genetics, Inc
2.15% BioMarin Pharmaceutical Inc
2.13% United Therapeutics Corporation
2.13% Vertex Pharmaceuticals Incorporated
1.91% Gilead Sciences, Inc
1.87% Sarepta Therapeutics, Inc

Minafi - The intersection of FI, minimalism & mindfulness.

Don't miss out on new posts, courses, interactive articles and more!

Join & Get Your First Course Free

© 2024   Adam Fortuna

Site Map
Triangle Graduation Cap Angle Down Book regular Phone laptop regular fire regular fire regular search regular Acorn duotone Seedling duotone thumbs down duo thumbs up duo